GEN Exclusives

More »

GEN News Highlights

More »
Dec 20, 2006

QLT Earmarks $1.45M for AMD Research at Wilmer Eye Institute

  • QLT will research and develop potential treatments for dry age-related macular degeneration (AMD), under a two-year research collaboration and option agreement with the Wilmer Eye Institute at Johns Hopkins University.

    The agreement provides QLT with the first option to negotiate an exclusive license to patented products resulting from the research that could ultimately prevent the production and accumulation of toxic lipids in the eye that are believed to be key early events in dry AMD.

    Under the terms of the agreement, Johns Hopkins University will receive $1.45 million in research funding over two years. If QLT exercises its license option, it will pay Johns Hopkins certain financial milestones and royalties.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »